Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

A 37-year-old man with hair loss and skin issues was successfully treated with oral antibiotics, highlighting the need for early treatment. Long-term care includes low-dose antibiotics and avoiding caps and wigs.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

FFA's causes may include environmental triggers and genetic factors.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Trichoscopy can reliably distinguish between alopecia areata and trichotillomania.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

New understanding and treatments for hair loss are improving, but more research is needed.

Acne keloidalis nuchae is a chronic skin condition more common in African men, causing itchy or painful bumps and can lead to permanent hair loss if not treated early.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

No established treatment effectively stops inflammation and prevents hair loss in folliculitis decalvans.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

The dermatology book is useful but has some organizational issues.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Scalp condition healed with prednisone and tacrolimus.

Platelet-rich plasma can help treat scarring hair loss caused by Discoid Lupus Erythematosus.

PRP treatment mildly to moderately improves hair loss in most men with AGA.